Multiplex Assay Kit for Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay)

AOC1; DAO; KAO; Histaminase; Kidney amine oxidase; Diamine Oxidase; Amiloride-sensitive amine oxidase; Amine oxidase copper domain-containing protein 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-93 85
EDTA plasma(n=5) 85-97 89
heparin plasma(n=5) 97-104 101
sodium citrate plasma(n=5) 95-104 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-104% 84-98% 88-97% 78-104%
EDTA plasma(n=5) 92-99% 98-105% 88-102% 94-101%
heparin plasma(n=5) 92-103% 95-105% 97-105% 92-101%
sodium citrate plasma(n=5) 80-102% 84-99% 89-97% 90-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ABP1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Applied Clay Science Effects of copper-exchanged montmorillonite, as alternative to antibiotic, on diarrhea, intestinal permeability and proinflammatory cytokine of weanling pigs Cas.zju: Source
Phytomedicine.? A multi-component herbal preparation, STW 5, shows anti-apoptotic effects in radiation induced intestinal mucositis in rats Pubmed:25022208
Oxid Med Cell Longev Elevation of HO-1 Expression Mitigates Intestinal Ischemia-Reperfusion Injury and Restores Tight Junction Function in a Rat Liver Transplantation Model PubMed: 26064429
Pancreatology. Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis. Pubmed:26804005
 Biochimica et Biophysica Acta (BBA)-General Subjects Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats pubmed:28341485
Journal of Controlled Release A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury pubmed:28522195
Advances in Experimental Medicine and Biology Serum Diamine Oxidase in Pseudoallergy in the Pediatric Population pubmed:28804811
PLoS One Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats pubmed:28622357
Nutrients Protective Effect of Aplysin Supplementation on Intestinal Permeability and Microbiota in Rats Treated with Ethanol and Iron Pubmed:29861488
Scientific Reports Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia Pubmed:29679053
British Journal of Nutrition Postoperative symbiotic in patients with head and neck cancer: a double-blind randomised trial Pubmed:29277158
Food & Function The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer Pubmed:29384543
硕士论文 LOCALIZATION OF COPPER-CONTAINING AMINE OXIDASE ENZYMES IN THE BLOOD
International Journal of Clinical and Experimental Medicine Effects of fecal microbiota transplantation and joint application of probiotics on rats with alcoholic liver disease
Journal of Functional Foods Potent anti-inflammatory activity of polysaccharides extracted from Blidingia minima and their effect in a mouse model of inflammatory bowel disease
Acta Diabetologica Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice Pubmed: 31749050
Biomed Research International Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet Pubmed: 32149099
FASEB JOURNAL HMGB1‐associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats Pubmed: 31961020
JOURNAL OF ETHNOPHARMACOLOGY The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer Pubmed: 33039631
Cell Death Discovery Fecal microbiota transplantation from patients with autoimmune encephalitis modulates Th17 response and relevant behaviors in mice Pubmed: 32821439
The Journal of Nutritional Biochemistry Effects of fucoidan on tumor prevention and gut flora
Chemical Biology & Dug Design Design and development of novel fasudil derivatives as potent anti‐breast cancer agent that improves intestinal flora and intestinal barrier function in rats 34587363
Journal of Functional Foods Bovine lactoferricin ameliorates intestinal inflammation and mucosal barrier lesions in colitis through NF-κB/NLRP3 signaling pathways
Stem Cell Research & Therapy Transplanted hair follicle mesenchymal stem cells alleviated small intestinal ischaemia–reperfusion injury via intrinsic and paracrine mechanisms in a rat model
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APA656Hu61 Active Amiloride Binding Protein 1 (ABP1) Cell culture; Activity Assays.
EPA656Hu61 Eukaryotic Amiloride Binding Protein 1 (ABP1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA656Hu01 Recombinant Amiloride Binding Protein 1 (ABP1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA656Hu02 Recombinant Amiloride Binding Protein 1 (ABP1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA656Hu01 Polyclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP; FCM
PAA656Hu02 Polyclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
LAA656Hu71 Biotin-Linked Polyclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC.
MAA656Hu22 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB,IHC
MAA656Hu21 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
MAA656Hu25 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
MAA656Hu27 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
MAA656Hu29 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
MAA656Hu23 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
MAA656Hu24 Monoclonal Antibody to Amiloride Binding Protein 1 (ABP1) WB; IHC; ICC; IP.
FAA656Hu02 Anti-Amiloride Binding Protein 1 (ABP1) Monoclonal Antibody Flow cytometry.
FAA656Hu04 Anti-Amiloride Binding Protein 1 (ABP1) Monoclonal Antibody FCM
FAA656Hu06 Anti-Amiloride Binding Protein 1 (ABP1) Monoclonal Antibody FCM
FAA656Hu08 Anti-Amiloride Binding Protein 1 (ABP1) Monoclonal Antibody FCM
SEA656Hu ELISA Kit for Amiloride Binding Protein 1 (ABP1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA656Hu Multiplex Assay Kit for Amiloride Binding Protein 1 (ABP1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.